Risk of Declining Valuations of Unlisted Healthcare-Related Shares
First written in FY2022. 2 of 4 entries say "Materialised", first in FY2024. Latest entry: FY2025.
The whole theme swung hardest in 2026: 35 of 80 companies on the "Worse" side.
- FY2025MaterialisedAnnual report
「The extraordinary loss was primarily attributable to a ¥9.999 million loss on valuation of investment securities.」
The risk of declines in the value of unlisted shares and other securities materialized during the fiscal year as a ¥9.999 million loss on valuation of investment securities. The unlisted shares comprise 3 issues, with a total carrying amount of ¥20.400 million. - FY2024MaterialisedAnnual report
「The extraordinary loss was primarily attributable to a ¥10.030 million loss on valuation of investment securities.」
The risk of declines in the value of unlisted shares and other securities materialized as a ¥10.030 million loss on valuation of investment securities. - FY2023WorsenedAnnual report
「We hold unlisted IT- and healthcare-related shares and other securities. A deterioration in the financial condition or failure of an investee could reduce the value of our investment securities and affect our operating results and financial position.」
The scope of the risk expanded from healthcare-related holdings to IT- and healthcare-related holdings. The unlisted shares comprise 2 issues, with a total carrying amount of ¥20.030 million. During the fiscal year, the company also acquired ¥10.030 million of such shares. - FY2022First statedAnnual report
「We hold unlisted healthcare-related shares and other securities. A deterioration in the financial condition or failure of an investee could reduce the value of our investment securities and affect our operating results and financial position.」
The risk of declines in the value of unlisted healthcare-related shares and other securities is disclosed for the first time as a separate risk item.